These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20683963)

  • 21. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.
    Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F
    Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
    Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
    J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma.
    Lin ZZ; Hsu C; Jeng YM; Hu FC; Pan HW; Wu YM; Hsu HC; Hu MC; Cheng AL
    Liver Int; 2019 Sep; 39(9):1682-1691. PubMed ID: 30698907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.
    Liu WY; Xie DM; Zhu GQ; Huang GQ; Lin YQ; Wang LR; Shi KQ; Hu B; Braddock M; Chen YP; Zheng MH
    Expert Opin Ther Targets; 2015 May; 19(5):675-85. PubMed ID: 25547779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling.
    Tian S; Chen M; Wang B; Han Y; Shang H; Chen J
    Ann Hepatol; 2021; 20():100259. PubMed ID: 32980439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF19 and FGFR4 promotes the progression of gallbladder carcinoma in an autocrine pathway dependent on GPBAR1-cAMP-EGR1 axis.
    Chen T; Liu H; Liu Z; Li K; Qin R; Wang Y; Liu J; Li Z; Gao Q; Pan C; Yang F; Zhao W; Zhang Z; Xu Y
    Oncogene; 2021 Jul; 40(30):4941-4953. PubMed ID: 34163030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor receptor 4 regulates proliferation, anti-apoptosis and alpha-fetoprotein secretion during hepatocellular carcinoma progression and represents a potential target for therapeutic intervention.
    Ho HK; Pok S; Streit S; Ruhe JE; Hart S; Lim KS; Loo HL; Aung MO; Lim SG; Ullrich A
    J Hepatol; 2009 Jan; 50(1):118-27. PubMed ID: 19008009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function.
    Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C
    FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways.
    Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J
    PLoS One; 2011 Mar; 6(3):e17868. PubMed ID: 21437243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FGF19/FGFR4 signaling axis confines and switches the role of melatonin in head and neck cancer metastasis.
    Lang L; Xiong Y; Prieto-Dominguez N; Loveless R; Jensen C; Shay C; Teng Y
    J Exp Clin Cancer Res; 2021 Mar; 40(1):93. PubMed ID: 33691750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-receptor requirements for fibroblast growth factor-19 signaling.
    Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylation of FGFR4 in cholangiocarcinoma regulates receptor processing and cancer signaling.
    Phillips AJ; Lobl MB; Hafeji YA; Safranek HR; Mohr AM; Mott JL
    J Cell Biochem; 2022 Mar; 123(3):568-580. PubMed ID: 34981854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FGF19-FGFR4 signaling elaborates lens induction with the FGF8-L-Maf cascade in the chick embryo.
    Kurose H; Okamoto M; Shimizu M; Bito T; Marcelle C; Noji S; Ohuchi H
    Dev Growth Differ; 2005 May; 47(4):213-23. PubMed ID: 15921496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR redundancy limits the efficacy of FGFR4-selective inhibitors in hepatocellular carcinoma.
    Tao Z; Cui Y; Xu X; Han T
    Proc Natl Acad Sci U S A; 2022 Oct; 119(40):e2208844119. PubMed ID: 36179047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1.
    Guo C; Zhou N; Lu Y; Mu M; Li Z; Zhang X; Tu L; Du J; Li X; Huang D; Xu Q; Zheng X
    Biomed Pharmacother; 2024 Jan; 170():115955. PubMed ID: 38048735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.
    Wunsch E; Milkiewicz M; Wasik U; Trottier J; Kempińska-Podhorodecka A; Elias E; Barbier O; Milkiewicz P
    Sci Rep; 2015 Aug; 5():13462. PubMed ID: 26293907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibroblast growth factor receptor 4 promotes progression and correlates to poor prognosis in cholangiocarcinoma.
    Xu YF; Yang XQ; Lu XF; Guo S; Liu Y; Iqbal M; Ning SL; Yang H; Suo N; Chen YX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):54-60. PubMed ID: 24565842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibroblast growth factor receptor 4 regulates tumor invasion by coupling fibroblast growth factor signaling to extracellular matrix degradation.
    Sugiyama N; Varjosalo M; Meller P; Lohi J; Hyytiäinen M; Kilpinen S; Kallioniemi O; Ingvarsen S; Engelholm LH; Taipale J; Alitalo K; Keski-Oja J; Lehti K
    Cancer Res; 2010 Oct; 70(20):7851-61. PubMed ID: 20876804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.
    Desnoyers LR; Pai R; Ferrando RE; Hötzel K; Le T; Ross J; Carano R; D'Souza A; Qing J; Mohtashemi I; Ashkenazi A; French DM
    Oncogene; 2008 Jan; 27(1):85-97. PubMed ID: 17599042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.
    Wu X; Li Y
    Aging (Albany NY); 2009 Dec; 1(12):1023-7. PubMed ID: 20157585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.